Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03586973 |
|---|---|
| Brief Title: | A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma |
| First Submitted : | June 29, 2018 |
| First Submitted that Met QC Criteria : | July 12, 2018 |
| First Posted : | July 16, 2018 |
| Results First Submitted : | June 14, 2022 |
| Results First Submitted that Met QC Criteria : | April 17, 2023 |
| Results First Posted : | April 18, 2023 |
| Last Update Submitted that Met QC Criteria : | April 17, 2023 |
| Last Update Posted : | April 18, 2023 |